Satio wins $3.5M contract to develop at-home transdermal drug delivery device

The SatioRx transdermal drug delivery device. [Image from the company’s website]Satio announced that a National Institutes for Health agency awarded it a $3.5 million Small Business Innovation Research (SBIR) contract.

Awarded by the NIH’s Advanced Research Projects Agency for Health (ARPA-H), the contract helps the company develop SatioRx. This drug delivery device, compact and inexpensive, features disposable microneedle components for precise delivery. It remotely enables the delivery of a precise, metered dose of any liquid drug approved for transdermal delivery.

Under the contract, Boston-based Satio expects to leverage design features from its other patch-based devices. It also plans to utilize feasibility data from its manually operated transdermal delivery devices. Combining these, the company intends to develop a next-generation, remotely controllable device.

Get the full story at our sister site, Drug Delive…

Read more
  • 0

NIH to locate ARPA-H’s Catalyst Hub in Massachusetts

An agency within the National Institutes of Health (NIH) tabbed Massachusetts as the host of its Investor Catalyst Hub.

The federal Advanced Research Projects Agency for Health (ARPA-H) selected Massachusetts as the hub. It supports ARPA-H’s mission to foster collaboration among researchers, entrepreneurs and investors. The agency aims to accelerate innovative ideas that transform healthcare.

In a press briefing, ARPA-H Director Dr. Renee Wegrzyn announced the selection of Massachusetts. This formally launched ARPANET-H, a nationwide health innovation network comprised of three hubs across the U.S. ARPA-H chose Hadley, Massachusetts-based VentureWell to run and manage the Massachusetts-based hub. It will focus on helping the agency navigate the business and regulatory landscape and provide resources to bring ideas to market.

“This is a huge win for Massachusetts and an opportunity to bring economic development while strengthening our role as a nati…

Read more
  • 0

Massachusetts is competing for ARPA-H biomedical research center

[Image courtesy of Pixabay]The U.S. government is planning to establish the Advanced Research Projects Agency for Health (ARPA-H) to accelerate biomedical research.

The new federal research agency will not be based alongside its NIH parent in Bethesda, Maryland.

After winning authorization to create the agency, Sen. Edward J. Markey (D-Mass.) and several colleagues in Massachusetts are asking the Biden administration to locate the agency there.

Get the full story from our sister site, Drug Discovery & Development.

Read more
  • 0

Massachusetts is competing for ARPA-H biomedical research center

[Image courtesy of Pixabay]

The U.S. government is planning to establish the Advanced Research Projects Agency for Health (ARPA-H) to accelerate biomedical research.

The new federal research agency will not be based alongside its NIH parent in Bethesda, Maryland.

After winning authorization to create the agency, Sen. Edward J. Markey (D-Mass.) and several colleagues in Massachusetts are asking the Biden administration to locate the agency there.

The ARPA-H headquarters would also likely serve as a magnet for the broader life sciences industry.

In a letter to U.S. Secretary of Health and Human Services Xavier Becerra, Markey argues that Massachusetts is a premier biomedical research hub, given its talented workforce and network of elite universities, hospitals and research institutions.

“As ARPA-H seeks to accelerate medical breakthroughs and invest in high-risk, high-reward proj…

Read more
  • 0